SCHEMBL16655842

SCHEMBL16655842

NS(=O)(=O)c1ccc2c(c1)OC(F)(F)O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.53
CA2 P00918 11/20 0.43
CA1 P00915 9/20 0.43
CA9 Q16790 9/20 0.43
CA12 O43570 9/20 0.43
CA7 P43166 5/20 0.43
CA14 Q9ULX7 5/20 0.43
CA4 P22748 4/20 0.43
CA6 P23280 4/20 0.43
CA5A P35218 4/20 0.43
CA5B Q9Y2D0 4/20 0.43
LMNA P02545 1/20 0.40
CTNNB1 P35222 1/20 0.40
WNT3A P56704 1/20 0.40
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013203 0.81 KIF11 (0.53) KIF11CA2CA1CA9CA12
SCHEMBL3534174 0.81 KIF11 (0.45) KIF11CTNNB1WNT3ARAB9ANOTUM
SCHEMBL4558462 0.76 CNR1 (0.60) CA2CA1CA9CA12CA7
SCHEMBL13194642 0.74 CA2 (0.51) CA2CA1CA9CA12CA7
SCHEMBL16135859 0.72 SMYD3 (0.51) LMNARAB9AMAPTPKMNPC1
SCHEMBL3633865 0.71 CA2 (0.46) CA2CA1CA9CA12CA7
SCHEMBL21807839 0.70 KIF11 (0.45) KIF11CTNNB1WNT3ARAB9APKM
SCHEMBL167634 0.70 MAPT (0.55) KIF11CTNNB1WNT3ARAB9AKDM4E
SCHEMBL4404389 0.69 KIF11 (1.00) KIF11CA2CA1CA9CA12
SCHEMBL2005036 0.69 CA2 (0.74) KIF11CA2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057958-A1 AMINOTETRALINE AND AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY AbbVie Deutschland GmbH & Co. KG (DE) 2016-08-24 EP claimed
WO-2015055771-A1 AMINOTETRALINE AND AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY AbbVie Deutschland GmbH & Co. KG (DE) 2015-04-23 WO claimed